Symbol | Exchange | Currency |
|---|
Inogen (INGN) announces the appointment of Stanislav Glezeras the company's Executive Vice President and Chief Medical Officer, effective June 21, 2021.Glezer has over 25 years...
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more...
Inogen (INGN): Q1 GAAP EPS of $0.03 beats by $0.28.Revenue of $86.93M (-1.8% Y/Y) beats by $7.54M.Because of the uncertainties related to the COVID-19 pandemic, the Company is...
Shares of Inogen (NASDAQ:INGN), Inc. INGN reached a new 52-week high of $71.57 on Jul 12, before closing the session marginally lower at $71.42.Shares of the company have gained...
Phibro Animal Health (NASDAQ:PAHC) Corporation’s PAHC existing operations and established sales, marketing and distribution network in more than 65 countries provide it ample...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Sell | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Summary | Neutral | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,738.00 | 2,765.00 | 2,706.70 | +100.0 | +3.79% | 2.68M | NASDAQ | |||
| 372.13 | 377.54 | 367.00 | +4.32 | +1.17% | 11.45M | NASDAQ | |||
| 68.71 | 68.85 | 67.01 | +1.22 | +1.81% | 3.97M | NYSE | |||
| 43.41 | 43.45 | 42.26 | +1.32 | +3.12% | 24.72M | NYSE | |||
| 194.48 | 196.40 | 189.76 | +8.41 | +4.52% | 21.46M | NYSE | |||
| 27.61 | 27.66 | 26.56 | +1.62 | +6.23% | 6.10M | NASDAQ | |||
| 436.55 | 444.66 | 432.87 | -30.95 | -6.62% | 1.05M | NYSE | |||
| 91.90 | 92.77 | 85.27 | +12.37 | +15.55% | 15.30M | NASDAQ | |||
| 53.34 | 53.92 | 52.94 | +0.16 | +0.30% | 14.47M | NASDAQ | |||
| 39.02 | 39.33 | 36.08 | +1.01 | +2.66% | 45.08M | NYSE | |||
| 300.90 | 302.39 | 296.98 | +0.42 | +0.14% | 2.59M | NASDAQ | |||
| 75.67 | 75.90 | 74.39 | +1.45 | +1.95% | 7.25M | NASDAQ | |||
| 15.98 | 16.18 | 14.02 | +3.25 | +25.53% | 81.57M | NASDAQ | |||
| 41.52 | 41.87 | 39.80 | +2.16 | +5.49% | 41.40M | NYSE | |||
| 6.20 | 6.24 | 6.11 | +0.050 | +0.81% | 5.18M | NYSE |
Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.